Front. Nutr. Frontiers in Nutrition Front. Nutr. 2296-861X Frontiers Media S.A. 10.3389/fnut.2022.872237 Nutrition Correction Corrigendum: Trends in Obesity and Metabolic Status in Northern and Southern China Between 2012 and 2020 Li Ying 1 Yang Lin 2 3 Yin Lu 4 Liu Qingqi 5 Wang Yaqin 1 Yang Pingting 1 Wang Jiangang 1 Chen Zhiheng 1 Li Xiaohui 6 Yang Qinyu 6 He Yongmei 7 † Huang Xin 8 * † 1Department of Health Management, The Third Xiangya Hospital, Central South University, Changsha, China 2Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada 3Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada 4Medical Research & Biometrics Center, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 5Department of Biostatistics, Bioinformatics & Biomathematics, Georgetown University, Washington, DC, United States 6Department of Pharmacology, Xiangya School of Pharamceutical Science, Central South University, Changsha, China 7Department of Health Management, Aerospace Center Hospital, Beijing, China 8Department of Epidemiology, School of Medicine, Hunan Normal University, Changsha, China

Edited and reviewed by: Megan A. McCrory, Boston University, United States

 *Correspondence: Xin Huang xin.huang@hunnu.edu.cn

This article was submitted to Nutritional Epidemiology, a section of the journal Frontiers in Nutrition

†These authors have contributed equally to this work

 08 03 2022 2022 9 872237 09 02 2022 14 02 2022 Copyright © 2022 Li, Yang, Yin, Liu, Wang, Yang, Wang, Chen, Li, Yang, He and Huang. 2022 Li, Yang, Yin, Liu, Wang, Yang, Wang, Chen, Li, Yang, He and Huang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Trends in Obesity and Metabolic Status in Northern and Southern China Between 2012 and 2020 by Li, Y., Yang, L., Yin, L., Liu, Q., Wang, Y., Yang, P., Wang, J., Chen, Z., Li, X., Yang, Q., He, Y., and Huang, X. (2022). Front. Nutr. 8:811244. doi: 10.3389/fnut.2021.811244 obesity metabolic status trend series cross-sectional study China

In the original article, there were some mistakes in Table 1 as published. The means and SD of TG, TC, HDL-c, LDL-c, SBP, DBP and FSG in the non-obesity group were incorrect. The corrected Table 1 appears below.

Characteristics of selected study participants by obesity status.

Characteristics ObesityN (%) /mean (SD) Non-obesityN (%) /mean (SD)
Location** Northern China 35,953 (33.01) 220,829 (26.13)
Southern China 72,961 (66.99) 624,209 (73.87)
Sex** Female 23,584 (21.65) 386,537 (45.74)
Male 85,330 (78.35) 458,501 (54.26)
Age**, year (N = 953,952) 46.13 (14.20) 44.56 (14.79)
BMI, kg/m2 (N = 953,952) 30.10 (2.10) 23.11 (2.65)
TG**, mmol/L (N = 933,854) 2.46 (2.15) 1.53 (1.39)
TC**, mmol/L (N = 933,872) 5.14 (1.01) 4.90 (0.95)
HDL-c**, mmol/L (N = 923,832) 1.15 (0.29) 1.39 (0.39)
LDL-c**, mmol/L (N = 923,715) 2.84 (0.85) 2.72 (0.80)
SBP**, mmHg (N = 938,969) 132.81 (16.08) 121.36 (16.31)
DBP**, mmHg (N = 938,985) 83.27 (11.57) 74.79 (10.92)
FSG**, mmol/L (N = 942,864) 5.84 (1.61) 5.35 (1.18)
Hypertension** No 62,506 (58.53) 681,807 (81.93)
Yes 44,278 (41.47) 150,342 (18.07)
Diabetes** No 94,512 (87.50) 791,011 (94.75)
Yes 13,500 (12.50) 43,841 (5.25)
Dyslipidemia** No 40,345 (38.01) 546,177 (66.82)
Yes 65,785 (61.99) 271,260 (33.18)

p <0.01.

SD, standard deviation; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FSG, fasting serum glucose; TG, triglyceride; TC, total cholesterol; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol.

Obesity was defined as BMI ≥ 28 kg/m2.

Hypertension was defined as self-reported hypertension diagnosed by a physician, self-reported regular use of antihypertensive medications, or systolic/diastolic blood pressure at recruitment ≥ 140/90 mmHg.

Dyslipidemia was defined as meeting any of the following criteria: (1) TC ≥ 6.22 mmol/L; (2) LDL-C ≥ 4.14 mmol/L; (3) HDL-C <1.04 mmol/L; (4) TG ≥ 2.26 mmol/L; (5) self-reported dyslipidemia or use of lipid-lowering medications; Diabetes mellitus was defined as self-reported diabetes diagnosed by a physician, self-reported regular use of antidiabetic medications, or fasting glucose at recruitment ≥ 7.0 mmol/L.

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.